Jobs / United States / Eikon Therapeutics INC
Senior Scientist 1, Neuroscience
Eikon Therapeutics INC · 🇺🇸 New York, New York
Sponsorship verdict
Sponsorship possible
One solid signal, not two — worth applying, and worth asking about sponsorship early.
- Employer is on a government sponsor recordThe US Department of Labor certified 13 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
- The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
- No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
- Confirmed live todayWhen a source last listed this job as open.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence; it is not legal advice and never a guarantee — the employer and the immigration authority decide. Sign in to factor in where you can already work.
Or apply yourself on the official page →
Sponsor Radar — Eikon Therapeutics INC
The US Department of Labor certified 13 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Jun 2026) — the step every H-1B hire needs first. USCIS also records 1 H-1B approvals in FY2023. Source: LCA disclosure data (US Department of Labor (OFLC)).
Past sponsorship or register membership never guarantees sponsorship for this vacancy or for you. Full Sponsor Radar for Eikon Therapeutics INC →
About the role
Eikon Therapeutics is a new biopharmaceutical company employing revolutionary technology at the intersection of chemistry, engineering, computation, and biology to discover novel treatments for life-threatening diseases. Eikon’s discovery platform is built on groundbreaking innovations from its founders (Nobel Prize, 2014), culminating in the creation of microscopes which enable real time, molecular-resolution measurements of protein movement in living cells, thereby unlocking otherwise intractable classes of proteins as drug targets. Position We are seeking an enthusiastic and highly motivated Senior Scientist I to join our Neuroscience research team. In this role, you will be a key contributor to our efforts to identify and validate novel therapeutic targets for Parkinson’s disease. You will develop and apply complex cellular models and biochemical and cell-based assays to advance target validation and deepen our understanding of disease-relevant mechanisms. This is a highly collaborative, laboratory-focused role with the opportunity to work across disciplines and research sites, partnering with cellular and molecular biologists, in vivo pharmacologists, medicinal chemists, and other scientific colleagues to advance our neuroscience research programs. About You You are a collaborative and rigorous scientist who enjoys solving complex biological questions at the bench. You bring deep expertise in cellular and biochemical approaches and are comfortable independently designing, executing, and interpreting experiments while working as part of a multidisciplinary team. You thrive in a fast-paced research environment and enjoy translating scientific questions into well-designed experiments that can inform target validation and mechanism of action. You are an effective communicator and teammate who values scientific rigor, thoughtful collaboration, and the opportunity to support and develop more junior scientists. An interest in Parkinson’s disease and neurodegenerative biology, and in applying your expertise to drug discovery, will position you well for success in this role. What You’ll Do • Lead and support target validation and mechanism-of-action (MOA) assay development activities. • Execute in vitro experiments in cell lines, primary neurons, iPSC-derived neurons, and glia culture. • Build and execute biochemical and cell-based assays to support novel Parkinson’s disease target validation. • Collaborate with and support cellular and molecular biologists, in vivo pharmacologists, and medicinal chemists across research sites. • Support the training and guidance of junior research associates and interns, fostering a collaborative and productive research environment. • Stay up to date with the latest advancements in Parkinson’s disease research by attending relevant conferences and workshops. • Contribute to the preparation of research publications, presentations, and grant proposals, showcasing the team’s contributions to the field. • Maintain organized and comprehensive records of experiments, results, and protocols in adherence to company standards and regulatory requirements. • Uphold a culture of safety by strictly following laboratory protocols and promoting best practices in accordance with regulatory guidelines. Qualifications • Postdoc Fellowship plus 2 years of relevant experience or Ph.D. plus 5 years of relevant experience, or a Master’s degree plus 14 years of relevant experience or a Bachelor’s degree plus 16 years of relevant experience in Neuroscience, Cell Biology, Biochemistry, Pharmacology, or a related scientific discipline. • Highly proficient in cell culture techniques, including primary neurons and glia. • Proficiency with standard cell biology, biochemistry, enzymology, and neuroscience techni